This role is pivotal for launching empasiprubart, argenx's second therapeutic asset, to transform the Multifocal Motor Neuropathy treatment landscape.
Base: $168,000.00 - $231,000.00 USD; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive package including retirement savings and health benefits
Must-have
Nice-to-have
Not specified